Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-28T01:04:16.607Z Has data issue: false hasContentIssue false
  • English
  • Français

Comparison of the 6-minute walk test with established parameters for assessment of cardiopulmonary capacity in adults with complex congenital cardiac disease

Published online by Cambridge University Press:  13 July 2005

Andreas Niedeggen ,
Erik Skobel ,
Philipp Haager ,
Wolfgang Lepper ,
Eberhard Mühler  and
Andreas Franke
Andreas Niedeggen
Affiliation:
Department of Cardiology, University Hospital, Aachen, Germany
Erik Skobel
Affiliation:
Department of Cardiology, University Hospital, Aachen, Germany
Philipp Haager
Affiliation:
Department of Cardiology, University Hospital, Aachen, Germany
Wolfgang Lepper
Affiliation:
Department of Cardiology, University Hospital, Aachen, Germany
Eberhard Mühler
Affiliation:
Department of Paediatric Cardiology, University Hospital, Aachen, Germany
Andreas Franke
Affiliation:
Department of Cardiology, University Hospital, Aachen, Germany
Get access Rights & Permissions [Opens in a new window]

Abstract

Background: Objective assessment of the cardiopulmonary capacity in patients with complex congenital cardiac disease often remains difficult in clinical practice. The cardiopulmonary exercise test and determination of the levels of brain natriuretic peptide in the plasma are established tests, but expensive. The 6-minute walk test is also validated, but has not often been used in patients with heart failure due to congenital heart disease, nor compared with other tests. We sought to compare its value with the results of cardiopulmonary exercise testing and measuring the levels of brain natriuretic peptide in the plasma. Methods: We carried out a standardized 6-minute walk test in 31 patients with complex congenital cardiac disease on the same day that they underwent cardiopulmonary exercise testing and determination of levels of brain natriuretic peptide in the plasma. Of the patients, 7 had functionally univentricular hearts, 9 had transposition, 9 had tetralogy of Fallot, 3 had common arterial trunk, and 3 had pulmonary atresia with intact interventricular septum. Uptakes of oxygen at peak exercise, and at the anaerobic threshold, were determined using cardiopulmonary exercise testing, and classified as suggested by Weber. The 6-minute walk test was performed according to a standard protocol. Results: There was a significant correlation between brain natriuretic peptide, oxygen uptakes at peak exercise and 6-minute walk. The correlation between the 6-minute walk test and oxygen uptakes at the anaerobic threshold, however, was not significant. Conclusions: The 6-minute walk test can be performed easily, is inexpensive, widely available, and correlates well with measurements of brain natriuretic peptide and cardiopulmonary exercise testing, even in patients with corrected or palliated congenital cardiac malformations. A cut-off value of 450 metres in the 6-minute walk test allows a semi-quantitative classification in analogy to the classification suggested by Weber for cardiopulmonary exercise testing, and to a level of brain natriuretic peptide in the plasma of less or more than 100 picograms per millilitre.

Keywords

Heart failurebrain natriuretic peptideexercise capacity
Type
Original Article
Information
Cardiology in the Young , Volume 15 , Issue 4 , August 2005 , pp. 385 - 390
Copyright
© 2005 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bolger A, Coats A, Gatzoulis M. Congenital heart disease: the original heart failure syndrome. Eur Heart J 2003; 24: 970–976.Google Scholar
Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults. First of two parts. N Engl J Med 2000; 342: 256–263.Google Scholar
Webb CL, Jenkins KJ, Karpawich PP, et al. Collaborative care for adults with congenital heart disease. Circulation 2002; 105: 2318–2323.Google Scholar
Fredriksen PM, Chen A, Veldtman G, Hechter S, Therrien J, Webb G. Exercise capacity in adult patients with congenitally corrected transposition of the great arteries. Heart 2001; 85: 191–195.Google Scholar
Fredriksen P, Veldtman G, Hechter S, et al. Aerobic capacity in adults with various congenital heart diseases. Am J Cardiol 2001; 87: 310–314.Google Scholar
Fritsch J, Winter U, Kaemmerer H, Hilger H. Cardiopulmonary capacity of patients with congenital heart defects in childhood, adolescence and adulthood. Z Kardiol 1994; 83: 131–139.Google Scholar
Hechter S, Webb G, Fredriksen P, et al. Cardiopulmonary exercise performance in adult survivors of Mustard procedure. Cardiol Young 2001; 11: 407–414.Google Scholar
Kruger S, Graf J, Kunz D, Stickel T, Hanrath P, Janssens U. Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol 2002; 40: 718.Google Scholar
Kruger S, Hoffmann R, Graf J, Janssens U, Hanrath P. Brain natriuretic peptide: Diagnostische und prognostische Bedeutung bei chronischer Herzinsuffizienz. Med Klin 2003; 98: 562–567.Google Scholar
Mulders F, Kromer E, Griese D, et al. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. Am Heart J 2004; 134: 442–449.Google Scholar
Sinha A, Filzmaier K, Breithardt O, et al. Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patient with heart failure. Am J Cardiol 2003; 91: 755–758.Google Scholar
Tsutamoto T, Wada A, Madea K. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction – comparison with plasma angiotensin II and endothelin-1. Eur J Echocardiogr 1999; 20: 1799–1807.Google Scholar
Tulevski I, Groenink M, van der Wall E, et al. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction. Heart 2001; 86: 27–30.Google Scholar
Bolger AP, Sharma R, Li W, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002; 106: 92–99.Google Scholar
Hjortdal VE, Stenbog EV, Ravn HB, et al. Neurohormonal activation late after cavopulmonary connection. Heart 2000; 83: 439–443.Google Scholar
Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001; 119: 256–270.Google Scholar
Enright PL. The six-minute walk test. Respir Care 2003; 48: 783–785.Google Scholar
Garofano R, Barst R. Exercise testing in children with primary pulmonary hypertension. Pediatr Cardiol 1999; 20: 61–64.Google Scholar
Bittner V, Weiner DH, Yusuf S, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA 1993; 270: 1702–1707.Google Scholar
Haass M, Zugck C, Kübler W. The 6 minute walk test: a cost effective alternative to cardiopulmonary exercise testing in patients with congestive heart failure? Z Kardiol 2000; 89: 72–80.Google Scholar
Kuster G, Tanner H, Printzen G, Suter T, Mohacsi P, Hess O. B-type natriuretic peptide for diagnosis and treatment of congestive heart failure. Schweiz Med Wochenschr 2003; 133: 623–628.Google Scholar
Fischer Y, Filzmaier K, Stiegler S. Evaluation of a new rapid bedside test for quantitative determination of B-type natriuretic peptide. Clin Chem 2001; 47: 591–594.Google Scholar
Logeart D, Saudubray C, Beyne P, et al. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol 2002; 40: 1794–1800.Google Scholar
Beaver W, Wassermann K, Whipp B. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986; 60: 2020–2027.Google Scholar
Weber K, Janicki J, McElroy P. Determination of aerobic capacity and the severity of chronic cardiac and circulatory failure. Circulation 1987; 76: VI40–VI45.Google Scholar
ATS Statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111–117.
Helbing WA, Bosch HG, Maliepaard C, et al. Comparison of echocardiographic methods with magnetic resonance imaging for assessment of right ventricular function in children. Am J Cardiol 1995; 76: 589–594.Google Scholar
Wilson NJ, Neutze JM, Rutland MD, Ramage MC. Transthoracic echocardiography for right ventricular function late after the Mustard operation. Am Heart J 1996; 131: 360–367.Google Scholar
Cowie MR, Jourdain P, Maisel A, et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 2003; 24: 1710–1718.Google Scholar
Guyatt GH, Sullivan MJ, Thompson PJ, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985; 132: 919–923.Google Scholar
Zugck C, Kruger C, Durr S, et al. Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? Eur Heart J 2000; 21: 540–549.Google Scholar
Pinna DG, Opasich C, Mazza A, Tangenti A, Maestri R, Sanarico M. Reproducibility of the six-minute walking test in chronic heart failure patients. Stat Med 2000; 19: 3087–3094.Google Scholar